HTR1A and Anxiety: We further demonstrated that a chronic treatment with pindolol or tandospirone, partial and more efficacious 5-HT1A receptor agonists, respectively, reduces ethanol intake, prevents withdrawal-induced anxiety-like behaviour and reverses the deficits in hippocampal neurogenesis elicited by long-term ethanol intake in mice [28, 31].